These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22305413)

  • 41. Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England.
    Coelho JM; Turton JF; Kaufmann ME; Glover J; Woodford N; Warner M; Palepou MF; Pike R; Pitt TL; Patel BC; Livermore DM
    J Clin Microbiol; 2006 Oct; 44(10):3623-7. PubMed ID: 17021090
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections.
    Saballs M; Pujol M; Tubau F; Peña C; Montero A; Domínguez MA; Gudiol F; Ariza J
    J Antimicrob Chemother; 2006 Sep; 58(3):697-700. PubMed ID: 16895941
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multidrug-resistant Acinetobacter baumannii, Russia.
    Naas T; Kernbaum S; Allali S; Nordmann P
    Emerg Infect Dis; 2007 Apr; 13(4):669-71. PubMed ID: 17561578
    [No Abstract]   [Full Text] [Related]  

  • 44. Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model.
    Song JY; Cheong HJ; Lee J; Sung AK; Kim WJ
    Int J Antimicrob Agents; 2009 Jan; 33(1):33-9. PubMed ID: 18835761
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical outcomes of patients infected with carbapenem-resistant Acinetobacter baumannii treated with single or combination antibiotic therapy.
    Santimaleeworagun W; Wongpoowarak P; Chayakul P; Pattharachayakul S; Tansakul P; Garey KW
    J Med Assoc Thai; 2011 Jul; 94(7):863-70. PubMed ID: 21774295
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of multidrug- and carbapenem-resistant Acinetobacter baumannii in Canada: results from CANWARD 2007.
    McCracken M; DeCorby M; Fuller J; Loo V; Hoban DJ; Zhanel GG; Mulvey MR
    J Antimicrob Chemother; 2009 Sep; 64(3):552-5. PubMed ID: 19578083
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme.
    Yau W; Owen RJ; Poudyal A; Bell JM; Turnidge JD; Yu HH; Nation RL; Li J
    J Infect; 2009 Feb; 58(2):138-44. PubMed ID: 19058855
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea.
    Ko KS; Suh JY; Kwon KT; Jung SI; Park KH; Kang CI; Chung DR; Peck KR; Song JH
    J Antimicrob Chemother; 2007 Nov; 60(5):1163-7. PubMed ID: 17761499
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exposure to quinolones is associated with carbapenem resistance among colistin-susceptible Acinetobacter baumannii blood isolates.
    Kopterides P; Koletsi PK; Michalopoulos A; Falagas ME
    Int J Antimicrob Agents; 2007 Nov; 30(5):409-14. PubMed ID: 17851052
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections: clinical outcome and adverse events.
    Petrosillo N; Chinello P; Proietti MF; Cecchini L; Masala M; Franchi C; Venditti M; Esposito S; Nicastri E
    Clin Microbiol Infect; 2005 Aug; 11(8):682-3. PubMed ID: 16008625
    [No Abstract]   [Full Text] [Related]  

  • 51. Multidrug resistance in Pseudomonas aeruginosa isolated from nosocomial respiratory and urinary infections in Aleppo, Syria.
    Mahfoud M; Al Najjar M; Hamzeh AR
    J Infect Dev Ctries; 2015 Feb; 9(2):210-3. PubMed ID: 25699497
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antimicrobial resistance of nosocomial strain of Acinetobacter baumannii in Children's Medical Center of Tehran: a 6-year prospective study.
    Soroush S; Haghi-Ashtiani MT; Taheri-Kalani M; Emaneini M; Aligholi M; Sadeghifard N; Pakzad I; Abedini M; Yasemi M; Paiman H
    Acta Med Iran; 2010; 48(3):178-84. PubMed ID: 21137655
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40.
    Lolans K; Rice TW; Munoz-Price LS; Quinn JP
    Antimicrob Agents Chemother; 2006 Sep; 50(9):2941-5. PubMed ID: 16940085
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.
    Koomanachai P; Tiengrim S; Kiratisin P; Thamlikitkul V
    Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular findings and antibiotic-resistance in an outbreak of Acinetobacter baumannii in an intensive care unit.
    Longo B; Pantosti A; Luzzi I; Tarasi A; Di Sora F; Gallo S; Placanica P; Monaco M; Dionisi AM; Volpe I; Montella F; Cassone A; Rezza G
    Ann Ist Super Sanita; 2007; 43(1):83-8. PubMed ID: 17536158
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibiotic resistance determinants of multidrug-resistant Acinetobacter baumannii clinical isolates in Algeria.
    Bakour S; Touati A; Sahli F; Ameur AA; Haouchine D; Rolain JM
    Diagn Microbiol Infect Dis; 2013 Aug; 76(4):529-31. PubMed ID: 23688522
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of Acinetobacter baumannii carrying bla(OXA-23), bla(PER-1) and armA in a Korean hospital.
    Kim JW; Heo ST; Jin JS; Choi CH; Lee YC; Jeong YG; Kim SJ; Lee JC
    Clin Microbiol Infect; 2008 Jul; 14(7):716-8. PubMed ID: 18558945
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular epidemiology of carbapenem-non-susceptible Acinetobacter baumannii in Japan.
    Endo S; Yano H; Hirakata Y; Arai K; Kanamori H; Ogawa M; Shimojima M; Ishibashi N; Aoyagi T; Hatta M; Yamada M; Tokuda K; Kitagawa M; Kunishima H; Kaku M
    J Antimicrob Chemother; 2012 Jul; 67(7):1623-6. PubMed ID: 22447879
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Successful treatment of multidrug-resistant Acinetobacter baumannii central nervous system infections with colistin.
    Katragkou A; Roilides E
    J Clin Microbiol; 2005 Sep; 43(9):4916-7. PubMed ID: 16145177
    [No Abstract]   [Full Text] [Related]  

  • 60. Difference in imipenem, meropenem, sulbactam, and colistin nonsusceptibility trends among three phenotypically undifferentiated Acinetobacter baumannii complex in a medical center in Taiwan, 1997-2007.
    Liang-Yu C; Kuo SC; Liu CY; Luo BS; Huang LJ; Lee YT; Chen CP; Chen TL; Fung CP
    J Microbiol Immunol Infect; 2011 Oct; 44(5):358-63. PubMed ID: 21524973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.